Labcorp Holdings Inc. (LH)
NYSE: LH · Real-Time Price · USD
370.48
-1.84 (-0.49%)
Nov 13, 2026, 4:00 PM EST - Market closed
Labcorp Holdings Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 14,595 | 13,952 | 13,009 | 12,162 | 11,864 | 13,136 |
Revenue Growth | 6.02% | 7.25% | 6.97% | 2.51% | -9.69% | -6.03% |
Gross Profit Gross Profit Growth | 4,227 | 4,013 | 3,624 | 3,365 | 3,709 | 4,992 |
Operating Income Operating Income Growth | 1,631 | 1,505 | 1,138 | 1,113 | 1,752 | 3,161 |
Net Income Net Income Growth | 1,004 | 876.5 | 746 | 418 | 1,279 | 2,377 |
Earnings Per Share EPS Growth | 12.18 | 10.46 | 8.84 | 4.77 | 13.97 | 24.39 |
EPS Growth | 19.56% | 18.33% | 85.21% | -65.82% | -42.73% | 53.56% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Diagnostics (Dx) Diagnostics (Dx) Growth | 11,340 | 10,877 | 10,144 | 9,415 | 9,204 | 10,364 |
Biopharma Laboratory Services (BLS) Biopharma Laboratory Services (BLS) Growth | 3,277 | 3,098 | 2,923 | 2,774 | 2,697 | 2,861 |
Revenue (Total) Revenue (Total) Growth | 14,595 | 13,952 | 13,009 | 12,162 | 11,864 | 16,121 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 261.8 | 532.3 | 1,519 | 536.8 | 320.6 | 1,484 |
Total Debt Total Debt Growth | 6,848 | 6,526 | 7,273 | 6,024 | 6,246 | 6,343 |
Net Cash (Debt) Net Cash Growth | -6,586 | -5,994 | -5,754 | -5,487 | -5,926 | -4,859 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -79.95 | -71.52 | -68.18 | -62.64 | -64.69 | -49.84 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,815 | 1,641 | 1,586 | 1,328 | 1,847 | 3,018 |
Capital Expenditures CapEx Growth | -528.1 | -434.5 | -489.9 | -453.6 | -429.3 | -421.5 |
Free Cash Flow Free Cash Flow Growth | 1,287 | 1,206 | 1,096 | 874.1 | 1,417 | 2,597 |
Free Cash Flow Growth | -6.80% | 10.05% | 25.37% | -38.32% | -45.42% | 48.08% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 28.96% | 28.76% | 27.86% | 27.67% | 31.26% | 38.01% |
Operating Margin | 11.18% | 10.79% | 8.75% | 9.15% | 14.77% | 24.06% |
Pretax Margin | 8.39% | 7.94% | 7.38% | 4.68% | 10.43% | 21.98% |
Profit Margin | 6.88% | 6.28% | 5.73% | 3.44% | 10.78% | 18.10% |
FCF Margin | 8.82% | 8.64% | 8.42% | 7.19% | 11.95% | 19.77% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 2.880 | 2.880 | 2.880 | 2.880 | 2.160 |
Dividend Per Share Growth | 0% | 0% | 0% | 33.33% | - |
Dividend Yield | 0.78% | 1.14% | 1.25% | 1.25% | 0.91% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 15, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 30.42 | 23.73 | 25.71 | 46.17 | 16.31 | 12.65 |
Forward PE | 19.23 | 14.61 | 14.95 | 16.00 | 13.85 | 16.59 |
P/FCF Ratio | 23.38 | 17.25 | 17.50 | 22.08 | 14.72 | 11.58 |
PS Ratio | 2.06 | 1.49 | 1.47 | 1.59 | 1.76 | 2.29 |